Article
"And the trouble is, if you don't risk anything, you risk even more."
Glaucoma Research Foundation announces 2025 recipients of Shaffer Research Grants
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Kalaris and AlloVir Inc. complete merger
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Staying the course in shifting winds
Iantrek announces positive 2-year results from clinical study of its bio-interventional platform for uveoscleral outflow enhancement
